Nanovaccine boosts immunity in sufferers of metabolic syndrome
Thursday, March 28, 2019 - 07:30
in Health & Medicine
A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria – a population that shows resistance to traditional flu and polio vaccines.